 | |
 | |
| Clinical data | |
|---|---|
| Other names | Testiphenon; Testiphenone; Chlorphenacyl dihydrotestosterone ester; Dihydrotestosterone 17β-(4-(bis(2-chloroethyl)amino)phenyl)acetate; LS-19378 |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C31H43Cl2NO3 |
| Molar mass | 548.59 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Testifenon, also known astestiphenon,testiphenone,chlorphenacyl dihydrotestosterone ester, ordihydrotestosterone 17β-(4-(bis(2-chloroethyl)amino)phenyl)acetate, is asyntheticanabolic–androgenic steroid (AAS) and acytostaticantineoplastic agent (i.e.,chemotherapeutic) that was never marketed.[1][2][3] It is anandrogen ester – specifically, achlorphenacylnitrogen mustardester ofdihydrotestosterone (DHT) – and acts as aprodrug of these two components in the body.[1][2] The drug was developed inRussia as atissue-selectivecytostaticdrug for the treatment of variouscancers occurring inandrogen receptor-expressingtissues that would have reducedside effects andtoxicity relative to other chemotherapy drugs.[1][2]
 | Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byexpanding it. |
